The life expectancy for men aged 65 years in the U.S. has gradually increased since the 1960s. Now men in the United States aged 65 can expect to live 17 more years on average. Women aged 65 years can expect to live around 19.7 more years on average.

Life expectancy in the U.S.

As of 2021, the average life expectancy at birth in the United States was 76.33 years. Life expectancy in the U.S. had steadily increased for many years but has recently dropped slightly. Women consistently have a higher life expectancy than men but have also seen a slight decrease. As of 2019, a woman in the U.S. could be expected to live up to 79.3 years.

Leading causes of death

The leading causes of death in the United States include heart disease, cancer, unintentional injuries, chronic lower respiratory diseases and cerebrovascular diseases. However, heart disease and cancer account for around 38 percent of all deaths. Although heart disease and cancer are the leading causes of death for both men and women, there are slight variations in the leading causes of death. For example, unintentional injury and suicide account for a larger portion of deaths among men than they do among women.

This table contains 2394 series, with data for years 1991 - 1991 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (Not all combinations are available): Geography (1 items: Canada ...), Population group (19 items: Entire cohort; Income adequacy quintile 1 (lowest);Income adequacy quintile 2;Income adequacy quintile 3 ...), Age (14 items: At 25 years; At 30 years; At 40 years; At 35 years ...), Sex (3 items: Both sexes; Females; Males ...), Characteristics (3 items: Life expectancy; High 95% confidence interval; life expectancy; Low 95% confidence interval; life expectancy ...).

In 2022, the life expectancy at birth for women born in the UK was 82.57 years, compared with 78.57 years for men. By age 65 men had a life expectancy of 18.25 years, compared with 20.76 years for women.

Taiwan Life Expectancy: Male: Age 60 data was reported at 22.030 Year Old in 2017. This records an increase from the previous number of 21.792 Year Old for 2016. Taiwan Life Expectancy: Male: Age 60 data is updated yearly, averaging 20.516 Year Old from Dec 1993 (Median) to 2017, with 25 observations. The data reached an all-time high of 22.030 Year Old in 2017 and a record low of 18.050 Year Old in 1993. Taiwan Life Expectancy: Male: Age 60 data remains active status in CEIC and is reported by Ministry of the Interior. The data is categorized under Global Database’s Taiwan – Table TW.G006: Vital Statistics.

Over the past 160 years, life expectancy (from birth) in the United States has risen from 39.4 years in 1860, to 78.9 years in 2020. One of the major reasons for the overall increase of life expectancy in the last two centuries is the fact that the infant and child mortality rates have decreased by so much during this time. Medical advancements, fewer wars and improved living standards also mean that people are living longer than they did in previous centuries.

Despite this overall increase, the life expectancy dropped three times since 1860; from 1865 to 1870 during the American Civil War, from 1915 to 1920 during the First World War and following Spanish Flu epidemic, and it has dropped again between 2015 and now. The reason for the most recent drop in life expectancy is not a result of any specific event, but has been attributed to negative societal trends, such as unbalanced diets and sedentary lifestyles, high medical costs, and increasing rates of suicide and drug use.

In 2021, a woman in the United States aged 65 years could expect to live another 19.7 years on average. This number decreased in the years 2020 and 2021, after reaching a high of 20.8 years in 2019. Nevertheless, the life expectancy of a woman aged 65 years in the United States is still higher than that of a man of that age. In 2021, a man aged 65 years could be expected to live another 17 years on average.

Why has the life expectancy in the U.S. declined? Overall, life expectancy in the United States has declined in recent years. In 2019, the life expectancy for U.S. women was 81.4 years, but by 2021 it had decreased to 79.3 years. Likewise, the life expectancy for men decreased from 76.3 years to 73.5 years in the same period. The biggest contributors to this decline in life expectancy are the COVID-19 pandemic and the opioid epidemic. Although deaths from the COVID-19 pandemic have decreased significantly since 2022, deaths from opioid overdose continue to increase, reaching all-time highs in 2021.

The leading causes of death among U.S. women The leading causes of death among women in the United States in 2020 were heart disease, cancer, and COVID-19. That year heart disease and cancer accounted for a combined 37 percent of all deaths among women, while around 10 percent of deaths were due to COVID-19. The overall leading causes of death in the United States generally reflect the leading causes among women with some slight variations. For example, Alzheimer’s disease is the fourth leading cause of death among women, but the seventh leading cause of death overall in the United States.

This table contains mortality indicators by sex for Canada and all provinces except Prince Edward Island. These indicators are derived from three-year complete life tables. Mortality indicators derived from single-year life tables are also available (table 13-10-0837). For Prince Edward Island, Yukon, the Northwest Territories and Nunavut, mortality indicators derived from three-year abridged life tables are available (table 13-10-0140).

In 2019, a 65 year old female in Australia was expected to live a further 22.7 years, while men were expected live a further 20 years. Although the male life expectancy is around three years under the life expectancy of women, male life expectancy has continued to grow while the life expectancy of women remained constant for the previous three years.

Life expectancy at birth and at age 65, by sex, on a three-year average basis.

In 2024, life expectancy at 65 years was 21.2 years, compared to 20.9 in 2023. A 65-year-old man in Italy had an average life expectancy of another 19.8 years, while a 65-year-old woman could live 22.6 years more. Lately, the average life expectancy at birth in the north-eastern regions of Italy registered the highest figures.

70,60 (years) in 2010. Life Expectancy refers to the average number of years that people who already have lived to a certain age and can relive. It reflects integrated indicators of the level of human health and the level of death and is mainly affected by the level of social and economic conditions and health standards and other factors, and differs a lot in different societies and different period of time. In the case of not specified ages, the average life expectancy refers to life expectancy of the population aged 0.

This table contains 2754 series, with data for years 2005/2007 - 2012/2014 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (Not all combinations are available): Geography (153 items: Canada; Newfoundland and Labrador; Eastern Regional Integrated Health Authority, Newfoundland and Labrador; Central Regional Integrated Health Authority, Newfoundland and Labrador; ...); Age group (2 items: At birth; At age 65); Sex (3 items: Both sexes; Males; Females); Characteristics (3 items: Life expectancy; Low 95% confidence interval, life expectancy; High 95% confidence interval, life expectancy).

Japan life expectancy for 2025 is 85.27, a 0.14% increase from 2024.

<ul style='margin-top:20px;'>

<li>Japan life expectancy for 2024 was <strong>85.15</strong>, a <strong>0.14% increase</strong> from 2023.</li>
<li>Japan life expectancy for 2023 was <strong>85.03</strong>, a <strong>0.14% increase</strong> from 2022.</li>
<li>Japan life expectancy for 2022 was <strong>84.91</strong>, a <strong>0.14% increase</strong> from 2021.</li>
</ul>Life expectancy at birth indicates the number of years a newborn infant would live if prevailing patterns of mortality at the time of its birth were to stay the same throughout its life.

Male newborns in Germany had an average further life expectancy of 78.2 years, while for female newborns this was 83 years. German men aged 100 were expected to live another 1.7 years.

In 2022, the average life expectancy of women in Japan was approximately 87.1 years, whereas the life expectancy of men reached around 81.1 years. The average life expectancy of both men and women in Japan indicated a decrease for two consecutive years. Aging workforce Japan has one of the highest proportions of senior citizens worldwide, with almost 30 percent of the country’s population aged 65 years and older. The growing average life expectancy and declining fertility rates led to this demographic shift. To secure the nation's workforce despite the aging population, the Japanese government amended the Act on Stabilization of Employment of Elderly Persons in 2021 and requested Japanese enterprises to raise the retirement age to 70 for employees who wish to continue working after turning 60 or 65. Causes of death The leading causes of death in Japan are malignant neoplasms, heart diseases, and cerebrovascular diseases. Lung cancer is the most mortal cancer site among Japanese men and women, but its mortality risk has declined from the 1990s onward. This development can be partially attributed to the downward trend in tobacco consumption. Since peaking in the 1970s, tobacco consumption in Japan has steadily declined, noticeable from the continuous decrease in the cigarette industry’s annual sales volume growth. Apart from a growing awareness regarding health risks, this downward movement can be explained by a tightening of prefectural no-smoking policies in the streets, many restaurants, and public places in general.

It is only in the past two centuries where demographics and the development of human populations has emerged as a subject in its own right, as industrialization and improvements in medicine gave way to exponential growth of the world's population. There are very few known demographic studies conducted before the 1800s, which means that modern scholars have had to use a variety of documents from centuries gone by, along with archeological and anthropological studies, to try and gain a better understanding of the world's demographic development. Genealogical records One such method is the study of genealogical records from the past; luckily, there are many genealogies relating to European families that date back as far as medieval times. Unfortunately, however, all of these studies relate to families in the upper and elite classes; this is not entirely representative of the overall population as these families had a much higher standard of living and were less susceptible to famine or malnutrition than the average person (although elites were more likely to die during times of war). Nonetheless, there is much to be learned from this data. Impact of the Black Death In the centuries between 1200 and 1745, English male aristocrats who made it to their 21st birthday were generally expected to live to an age between 62 and 72 years old. The only century where life expectancy among this group was much lower was in the 1300s, where the Black Death caused life expectancy among adult English noblemen to drop to just 45 years. Experts assume that the pre-plague population of England was somewhere between four and seven million people in the thirteenth century, and just two million in the fourteenth century, meaning that Britain lost at least half of its population due to the plague. Although the plague only peaked in England for approximately eighteen months, between 1348 and 1350, it devastated the entire population, and further outbreaks in the following decades caused life expectancy in the decade to drop further. The bubonic plague did return to England sporadically until the mid-seventeenth century, although life expectancy among English male aristocrats rose again in the centuries following the worst outbreak, and even peaked at more than 71 years in the first half of the sixteenth century.

People in different subgroups age at different rates. Surveys containing biomarkers can be used to assess these subgroup differences. We illustrate this using hand-grip strength to produce an easily interpretable, physical-based measure that allows us to compare characteristic-based ages across educational subgroups in the United States. Hand-grip strength has been shown to be a good predictor of future mortality and morbidity, and therefore a useful indicator of population aging. Data from the Health and Retirement Survey (HRS) were used. Two education subgroups were distinguished, those with less than a high school diploma and those with more education. Regressions on hand-grip strength were run for each sex and race using age and education, their interactions and other covariates as independent variables. Ages of identical mean hand-grip strength across education groups were compared for people in the age range 60 to 80. The hand-grip strength of 65 year old white males with less education was the equivalent to that of 69.6 (68.2, 70.9) year old white men with more education, indicating that the more educated men had aged more slowly. This is a constant characteristic age, as defined in the Sanderson and Scherbov article “The characteristics approach to the measurement of population aging” published 2013 in Population and Development Review. Sixty-five year old white females with less education had the same average hand-grip strength as 69.4 (68.2, 70.7) year old white women with more education. African-American women at ages 60 and 65 with more education also aged more slowly than their less educated counterparts. African American men with more education aged at about the same rate as those with less education. This paper expands the toolkit of those interested in population aging by showing how survey data can be used to measure the differential extent of aging across subpopulations.

Philippines life expectancy for 2025 is 71.92, a 0.18% increase from 2024.

<ul style='margin-top:20px;'>

<li>Philippines life expectancy for 2024 was <strong>71.79</strong>, a <strong>0.18% increase</strong> from 2023.</li>
<li>Philippines life expectancy for 2023 was <strong>71.66</strong>, a <strong>0.18% increase</strong> from 2022.</li>
<li>Philippines life expectancy for 2022 was <strong>71.53</strong>, a <strong>0.18% increase</strong> from 2021.</li>
</ul>Life expectancy at birth indicates the number of years a newborn infant would live if prevailing patterns of mortality at the time of its birth were to stay the same throughout its life.

Background Detailed assessments of mortality patterns, particularly age-specific mortality, represent a crucial input that enables health systems to target interventions to specific populations. Understanding how all-cause mortality has changed with respect to development status can identify exemplars for best practice. To accomplish this, the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) estimated age-specific and sex-specific all-cause mortality between 1970 and 2016 for 195 countries and territories and at the subnational level for the five countries with a population greater than 200 million in 2016. Methods We have evaluated how well civil registration systems captured deaths using a set of demographic methods called death distribution methods for adults and from consideration of survey and census data for children younger than 5 years. We generated an overall assessment of completeness of registration of deaths by dividing registered deaths in each location-year by our estimate of all-age deaths generated from our overall estimation process. For 163 locations, including subnational units in countries with a population greater than 200 million with complete vital registration (VR) systems, our estimates were largely driven by the observed data, with corrections for small fluctuations in numbers and estimation for recent years where there were lags in data reporting (lags were variable by location, generally between 1 year and 6 years). For other locations, we took advantage of different data sources available to measure under-5 mortality rates (U5MR) using complete birth histories, summary birth histories, and incomplete VR with adjustments; we measured adult mortality rate (the probability of death in individuals aged 15-60 years) using adjusted incomplete VR, sibling histories, and household death recall. We used the U5MR and adult mortality rate, together with crude death rate due to HIV in the GBD model life table system, to estimate age-specific and sex-specific death rates for each location-year. Using various international databases, we identified fatal discontinuities, which we defined as increases in the death rate of more than one death per million, resulting from conflict and terrorism, natural disasters, major transport or technological accidents, and a subset of epidemic infectious diseases; these were added to estimates in the relevant years. In 47 countries with an identified peak adult prevalence for HIV/AIDS of more than 0.5% and where VR systems were less than 65% complete, we informed our estimates of age-sex-specific mortality using the Estimation and Projection Package (EPP)-Spectrum model fitted to national HIV/AIDS prevalence surveys and antenatal clinic serosurveillance systems. We estimated stillbirths, early neonatal, late neonatal, and childhood mortality using both survey and VR data in spatiotemporal Gaussian process regression models. We estimated abridged life tables for all location-years using age-specific death rates. We grouped locations into development quintiles based on the Sociodemographic Index (SDI) and analysed mortality trends by quintile. Using spline regression, we estimated the expected mortality rate for each age-sex group as a function of SDI. We identified countries with higher life expectancy than expected by comparing observed life expectancy to anticipated life expectancy on the basis of development status alone. Findings Completeness in the registration of deaths increased from 28% in 1970 to a peak of 45% in 2013; completeness was lower after 2013 because of lags in reporting. Total deaths in children younger than 5 years decreased from 1970 to 2016, and slower decreases occurred at ages 5-24 years. By contrast, numbers of adult deaths increased in each 5-year age bracket above the age of 25 years. The distribution of annualised rates of change in age-specific mortality rate differed over the period 2000 to 2016 compared with earlier decades: increasing annualised rates of change were less frequent, although rising annualised rates of change still occurred in some locations, particularly for adolescent and younger adult age groups. Rates of stillbirths and under-5 mortality both decreased globally from 1970. Evidence for global convergence of death rates was mixed; although the absolute difference between age-standardised death rates narrowed between countries at the lowest and highest levels of SDI, the ratio of these death rates-a measure of relative inequality-increased slightly. There was a strong shift between 1970 and 2016 toward higher life expectancy, most noticeably at higher levels of SDI. Among countries with populations greater than 1 million in 2016, life expectancy at birth was highest for women in Japan, at 86.9 years (95% UI 86.7-87.2), and for men in Singapore, at 81.3 years (78.8-83.7) in 2016. Male life expectancy was generally lower than female life expectancy between 1970 and 2016, and the gap be...

Italy life expectancy for 2025 is 84.26, a 0.15% increase from 2024.

<ul style='margin-top:20px;'>

<li>Italy life expectancy for 2024 was <strong>84.13</strong>, a <strong>0.15% increase</strong> from 2023.</li>
<li>Italy life expectancy for 2023 was <strong>84.00</strong>, a <strong>0.17% increase</strong> from 2022.</li>
<li>Italy life expectancy for 2022 was <strong>83.86</strong>, a <strong>0.17% increase</strong> from 2021.</li>
</ul>Life expectancy at birth indicates the number of years a newborn infant would live if prevailing patterns of mortality at the time of its birth were to stay the same throughout its life.